XiaoMi-AI文件搜索系统
World File Search Systemrenci
光子学系 - 准学生
我国第一个光子学系成立于 2015 年联合国教科文组织世界光年，隶属于 IZTECH 科学学院。该系旨在培养能够在该领域开展高级研究的科学家，并满足光子学领域公司对合格人力资源的需求，这需要多学科的教育和经验。光子学系于 2016-2017 学年春季学期开始硕士教育，2017-2018 学年春季学期开始博士教育，2019-2020 学年春季学期开始本科教育。
不同尺寸粒子增强PMMA复合材料的榛子
摘要Öz与技术的发展并行，数字屏幕已成为我们日常生活中必不可少的一部分。这导致眼睛与使用时间成比例。根据土耳其统计研究所（Tüİk）的“家庭信息技术使用调查”的结果，土耳其70％的家庭有一台计算机，而98.7％的家庭具有手机或智能手机。计算机视觉综合征描述了由于长期使用计算机而导致的一组眼睛和视力问题。症状包括眼睛疲劳，刺激，灼痛和头痛。由于没有综合征的单一原因，因此需要采用多方面的方法。除了经常出现症状外，人们对该主题的知识不足，缺乏适当的预防措施使计算机视觉综合征（CVS）成为一个重大的公共卫生问题。
2023行政年度报告伊斯坦布尔
表88。 Öğrenci Kontenjanları ve Doluluk Oranı ................................................................ 101 Tablo 89. İkametgahın Kayıtlı Olduğu İl Bazında Öğrenci Sayıları ......................................... 101 Tablo 90. 2023 MÜYÖS Bilgileri ............................................................................................. 102 Tablo 91. 2023穆耶斯的学生人数........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... Hizmet Birimlerinin Hasta ve Tetkik Bilgileri .......................................................... 104 Tablo 93. Nöroloji Birimleri Hizmet Bilgileri .......................................................................... 104 Tablo 94. Anabilim Dalı Bazında Hasta Sayıları ...................................................................... 105 Tablo 95. 根据部门（TL）106 106表96的总交易金额。 Radyolojik Tetkik Adedi .......................................................................................... 107 Tablo 97. Mediko-Sosyal Hizmet Bilgileri ............................................................................... 108 Tablo 98. yemek hizmeti verenyerleşkeler......................................................................................................................................................................................................................................................... 2023 Yılı Yemek Ücretleri ....................................................................................... 109 Tablo 100. 2023 Yılı Yemek Hizmetinden Yararlanan Kişi Sayısı ............................................ 109 Tablo 101.表88。Öğrenci Kontenjanları ve Doluluk Oranı ................................................................ 101 Tablo 89.İkametgahın Kayıtlı Olduğu İl Bazında Öğrenci Sayıları ......................................... 101 Tablo 90.2023 MÜYÖS Bilgileri ............................................................................................. 102 Tablo 91.2023穆耶斯的学生人数........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................Hizmet Birimlerinin Hasta ve Tetkik Bilgileri .......................................................... 104 Tablo 93.Nöroloji Birimleri Hizmet Bilgileri .......................................................................... 104 Tablo 94.Anabilim Dalı Bazında Hasta Sayıları ...................................................................... 105 Tablo 95.根据部门（TL）106 106表96的总交易金额。Radyolojik Tetkik Adedi .......................................................................................... 107 Tablo 97.Mediko-Sosyal Hizmet Bilgileri ............................................................................... 108 Tablo 98.yemek hizmeti verenyerleşkeler.........................................................................................................................................................................................................................................................2023 Yılı Yemek Ücretleri ....................................................................................... 109 Tablo 100.2023 Yılı Yemek Hizmetinden Yararlanan Kişi Sayısı ............................................ 109 Tablo 101.Kültürel Kurslar .................................................................................................... 111 Tablo 102.faaliyetTürlerivesayıları.................................................................................................................................................................................................................................Şehir İçi ve Şehirler Arası Görev Sayıları .............................................................. 114 Tablo 104.2023 Yılı Öğrenci Ring Seferleri ............................................................................. 115 Tablo 105.Üniversite Araç Bilgileri ........................................................................................ 115 Tablo 106.İş Makinası Bilgileri ............................................................................................... 116 Tablo 107.Kiralık Araç Bilgileri ............................................................................................... 116 Tablo 108.Kulüp İsimleri........................................................................................................ 116 Tablo 109.bilimsel projesayılarıBilgileri.................................................................................................................................................................................................................................................................按菲尔德人对科学研究项目的分配和预算。122表111。Birimlere Göre Proje Sayıları ve Bütçeleri ............................................................ 124 Tablo 112.BAPKO Bütçesinden Yapılan Harcamalar ............................................................. 125 Tablo 113.Birimlere Göre TÜBİTAK Proje Bilgileri ................................................................ 126 Tablo 114.diğerProjeler ve bilgileri .................................................................................................................................................................................................................................................................................................................2023YılındaYapılanPateNtBaşvuruları.........................................................................................................................................................................................................................................................................................................................................2023年的专利注册2023年制作的有用模型应用Bilimsel Hakemliklerin Yıllara Göre Dağılımı ........................................................ 131 Tablo 119.2023 Yılında Tamamlanan Bilimsel Araştırma Projelerinden Üretilen Yayın Tablosu ................................................................................................................................... 131 Tablo 120.Akademik Teşvik Alan Öğretim Elemanı Dağılımı ................................................ 131 Tablo 121.Kurumsal İletişim Koordinatörlüğü Faaliyet Verileri ............................................ 132 Tablo 122.Marmara Üniversitesi Sosyal Medya Durum Analizi ............................................ 133 Tablo 123.Kariyer Merkezi Faaliyetleri .................................................................................. 133 Tablo 124.Bursa Alan Öğrenci Sayısı .................................................................................................................................................................................................................................................................................................................................................ERASMUS Gelen-Giden Öğrenci Sayıları .............................................................. 138 Tablo 126.伊拉斯mus人数............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MarmaraüniversItesiuluslararasıAnlaşmalarve te原子器.................................................................................................................................................................................................................................................................................................................................................................................................Farabi Değişim Programı İkili Anlaşmalar ............................................................ 153 Tablo 129.eğitim-ÖğretimDönemlerineGörefarabiöğrenciSayıları.......................................................................................................................................................................................................................................................Mahkeme Dava Bilgileri ....................................................................................... 156 Tablo 131.Numerical data on the cases where our university is dealing with ......................... 157 Table 132. 在2023年开放并转移了...Numerical data on the cases where our university is dealing with ......................... 157 Table 132.在2023年开放并转移了...
教授博士AYFER ULGENALP - AVESIS
教授博士AYFER ÜLGENALP 个人信息 电子邮件：ayfer.ulgenalp@deu.edu.tr 网址：https://avesis.deu.edu.tr/ayfer.ulgenalp 国际研究人员 ID ORCID：0000-0002-9969-203X Publons / Web Of Science ResearcherID：EBP-1118-2022 Yoksis 研究人员 ID：11446 教育信息 博士学位，哈塞特佩大学医学院，土耳其 1989 - 1993 硕士学位，古尔哈内军事医学院，军事医学院，基础医学系，土耳其 1985 - 1988 学士学位，哈塞特佩大学，理学院，生物系，土耳其 1977 - 1982 论文 博士学位，通过聚合酶链反应间接诊断杜氏肌营养不良症，哈塞特佩大学医学院，1993 硕士学位，细胞中单纯疱疹 1 型早期抗原的定位，古尔哈内军事医学院，军事医学系，1988 年学术头衔/职责教授博士，多库兹艾鲁尔大学，医学院，内科系，2010 年至今 学术管理经验 多库兹艾鲁尔大学，2018 年至今 多库兹艾鲁尔大学，2015 年 - 2018 年 指导论文 Ülgenalp A.，使用“新一代 DNA 测序 - NGS”方法研究家族性高胆固醇血症相关基因，具有单中心经验，医学专业，D.ÖZKAY（学生），2023 年 Ülgenalp A.，通过全外显子组测序回顾性研究遗传性视网膜营养不良的遗传病因，医学专业，Z.KELEŞ（学生），2022 年 Ülgenalp A.， GBA1（葡萄糖神经酰胺酶 β1）基因变异与帕金森病关联的回顾性研究，医学系，H.YÜCEL（学生），2022 年 ÜLGENALP A.，在非免疫性胎儿积水病例中使用全外显子组序列确定候选基因，医学系，A.KEKİLLİ（学生），2021 年
胰腺癌的精确医学
B. Physiopathology of pancreatic cancer ....................................................................... 23 1.Epidemiology of pancreas cancer ............................................................................................ 23 I) Incidence and prevalence ...........................................................................................................................................................................................................................................................................................Precancerous lesions of the pancreas ................................................................................................................. 27 i) intra-epithelial pancreatic neoplasias ....................................................................................................................................................................................................... and mucing tumors ........................................................................................................................ 29 iii）cystadénom...............................................................................................................................................................................................................................................................................................................................................................................................................................................................PDAC的分子金属分类................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 36Histological characterization of pancreas cancers .............................................................................. 31 i) Adenocarcinoma canal of pancreas (PDAC) ............................................................... 31 II) Immunohistochemical markers of PDAC ........................................................................................... 33 III) Other PDAC subtypes ... 34 (1) Carcinome adénosquameux ..................................................................................................... 34 (2) Carcinome anaplasique ou indifférencié .................................................................................. 34 (3) Carcinome mucineux non kystique ........................................................................................... 34 iv) Caractéristiques du stroma ........................................................................................................... 35 4.
确保人口大数据的隐私和专有权......
Hye-Chung Kum，博士，社会工作硕士（德克萨斯农工大学-TAMU、SPH 和 TEES）：项目负责人。负责协调和支持所有必需的活动，包括参与网络基础设施的设计、共同领导数据治理工作、领导与 RENCI 合作的外展活动以及担任德克萨斯州数据资产用例的数据保管人。此外，德克萨斯农工大学将成立一个道德小组，该小组由使用大数据进行人类受试者研究的国家专家组成，在此类研究中，获得知情同意是不切实际的。所有用例都必须向道德小组提交 IRB 类申请，道德小组将评估研究中侵犯隐私的风险，同时考虑数据、所需的软件/算法、使用的计算基础设施以及谁需要访问哪些数据，包括哪些数据已向公众发布（例如，在出版物中）。我们将通过为给定用例分配所需的安全计算来将风险降至最低。该小组将为每个项目提供一份书面风险评估，他们可以将其提交给所在机构的 IRB，以促进使用大数据进行人类受试者研究的 IRB 流程更好（例如，开始构建有关数据隐私风险的通用词汇表）。Ari Kahn，博士（德克萨斯大学奥斯汀分校，TACC）：网络基础设施负责人。负责 (1) 通过虚拟化和安全网络访问为所有数据资产和用例提供安全的计算和存储（HIPAA、FISMA 中等等），(2)
深入奇妙的人工智能世界
1.项目启动，学生和访客注册到twinspace； 2.教师网络研讨会，设定目标，对教师和学生进行预先调查； 3.老师制作的标志； 4.学生的海报活动； 5.标志和海报调查。6.头像是在 Pixton 中制作的，并上传到每个学生的个人资料中。
实习作业主题和学生...
No Student NO STUDENT NAME AND SURNAME HOMEWORK NUMBER 1 17240003009 HAKAN TEKİN 1 2 17240003022 Serdar Başak 2 3 18240003006 Ümit Sarihan 3 4 19240003015 Ferit Yalçın 4 5 19240003017 Abdullah spouse 5 6 19240003031 İbrahim Duman 6 7 19240003035 Aziret 8 9 19240003039 Musa Seyitoglu 9 10 19240003040 CanerKarakuş1011 20240003002 Tefik Oguz 11 12 20240003003 AbdulmalikYürler 20240003009 SerhatAydın1718 20240003011 saban Bulut 18 19 20240003012 YunusEmreCanğa19 20240003013 Ebdullah Enk 20 21 20240003014 Sinan Sinan Live Live 21 22 20240003015 20240003021 Mustafa Akbal 26 27 20240003022 Abdullah Hakan Tulay 27 28 20240003023 RahmiErdoğan28 29 20240003024 Rojhat ihahatibe在çevík3334 2024000303 20240003032 YUSUF损坏35 36 20240003034OğuzAtaöz363720240003035MücahítAkbal37 37 38 20240003036 Furkan Aydin 38No Student NO STUDENT NAME AND SURNAME HOMEWORK NUMBER 1 17240003009 HAKAN TEKİN 1 2 17240003022 Serdar Başak 2 3 18240003006 Ümit Sarihan 3 4 19240003015 Ferit Yalçın 4 5 19240003017 Abdullah spouse 5 6 19240003031 İbrahim Duman 6 7 19240003035 Aziret 8 9 19240003039 Musa Seyitoglu 9 10 19240003040 CanerKarakuş1011 20240003002 Tefik Oguz 11 12 20240003003 AbdulmalikYürler 20240003009 SerhatAydın1718 20240003011 saban Bulut 18 19 20240003012 YunusEmreCanğa19 20240003013 Ebdullah Enk 20 21 20240003014 Sinan Sinan Live Live 21 22 20240003015 20240003021 Mustafa Akbal 26 27 20240003022 Abdullah Hakan Tulay 27 28 20240003023 RahmiErdoğan28 29 20240003024 Rojhat ihahatibe在çevík3334 2024000303 20240003032 YUSUF损坏35 36 20240003034OğuzAtaöz363720240003035MücahítAkbal37 37 38 20240003036 Furkan Aydin 38
2022 年金融稳定回顾
第一个框检查住宅物业价格和利率之间的非线性关系。撇开卢森堡房地产市场的供需约束不谈，所采用的模型对参数施加了约束，从而产生了与理论一致的弹性迹象。第二个方框建议根据 CRS/2020/005 建议书，根据授信标准和价格指标，评估卢森堡启动差别化贷款价值比率限额的有效性。预测和房地产贷款。第三个框基于所谓的“风险价格”方法，旨在估计卢森堡住宅房地产价格最大跌幅风险的重要性。